<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To investigate genetic prothrombotic factors (factor V Leiden and prothrombin gene G20210A mutations) and their relation with <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e> in ocular <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Thirty <z:chebi fb="6" ids="22696">Beh</z:chebi>çet patients were prospectively recruited into the study </plain></SENT>
<SENT sid="2" pm="."><plain>Their mean age was 34.2 +/- 8.3 years </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients underwent complete ophthalmic examination and <z:chebi fb="0" ids="31624">fluorescein</z:chebi> angiography </plain></SENT>
<SENT sid="4" pm="."><plain>Of the 30 patients, 15 (16 eyes) had <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Patients were tested for the presence of factor V Leiden and prothrombin gene G20210A mutations by polymerase chain reaction </plain></SENT>
<SENT sid="6" pm="."><plain>The results were compared with the frequencies of factor V Leiden in 285 and prothrombin gene G20210A mutation in 182 healthy members of the Turkish population </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: The prevalence of <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> was significantly higher in ocular <z:chebi fb="6" ids="22696">Beh</z:chebi>çet patients (12/30, 40%), compared with healthy control subjects (28/285, 9.8%) (p &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>Of the 12 Behçet patients with <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e>, eight had <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The prevalence of factor V Leiden was 53.3% (8/15) of the 15 patients with <z:chebi fb="46" ids="15035">retinal</z:chebi> <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> and 26.7% (4/15) of the remaining 15 patients without <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Prothrombin gene mutation was detected in none of <z:chebi fb="6" ids="22696">Beh</z:chebi>çet patients compared with 2.7% (5/182) of the control group </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: These data suggest that factor V Leiden may be an additional risk factor in ocular <z:chebi fb="6" ids="22696">Beh</z:chebi>çet disease, whereas <z:e sem="disease" ids="C1610621" disease_type="Disease or Syndrome" abbrv="">factor II mutations</z:e> do not seem to be relevant </plain></SENT>
</text></document>